Related references
Note: Only part of the references are listed.Hsp90 and Co-Chaperones Twist the Functions of Diverse Client Proteins
Abbey Zuehlke et al.
BIOPOLYMERS (2010)
Elevated expression of nuclear Hsp90 in invasive breast tumors
Malissa C. Diehl et al.
CANCER BIOLOGY & THERAPY (2009)
Guidelines for the nomenclature of the human heat shock proteins
Harm H. Kampinga et al.
CELL STRESS & CHAPERONES (2009)
Heat shock protein90 in lobular neoplasia of the breast
Flora Zagouri et al.
BMC CANCER (2008)
Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Joanna L. Holmes et al.
CANCER RESEARCH (2008)
Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer
Baocun Sun et al.
CLINICAL CANCER RESEARCH (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
High HSP90 expression is associated with decreased survival in breast cancer
Elah Pick et al.
CANCER RESEARCH (2007)
Heat shock proteins as emerging therapeutic targets
C Soti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents
Y Miyata
CURRENT PHARMACEUTICAL DESIGN (2005)
Hsp90: an emerging target for breast cancer therapy
J Beliakoff et al.
ANTI-CANCER DRUGS (2004)
Anomalous expression of the HLA-DR α and β chains in ovarian and other cancers
LBA Rangel et al.
CANCER BIOLOGY & THERAPY (2004)